Human Immunodeficiency Virus in Solid Organ Transplantation

被引:35
作者
Blumberg, E. A. [1 ]
Rogers, C. C. [2 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
Drug resistance; drug interaction; highly active antiretroviral therapy; human immunodeficiency virus; reverse transcriptase inhibitor; viral load; HIV-INFECTED PATIENTS; HEPATITIS-C-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; LONG-TERM OUTCOMES; LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; B-VIRUS; POSITIVE PATIENTS; RECIPIENTS;
D O I
10.1111/ajt.12109
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:169 / 178
页数:10
相关论文
共 64 条
  • [1] Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression
    Abbott, KC
    Swanson, SJ
    Agodoa, LYC
    Kimmel, PL
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06): : 1633 - 1639
  • [2] Simultaneous Pancreas Kidney Transplantation in the HIV-Positive Patient
    Akhtar, M. Z.
    Patel, N.
    Devaney, A.
    Sinha, S.
    Shankar, S.
    Vaidya, A.
    Friend, P. J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3903 - 3904
  • [3] Heart transplantation in HIV-infected patients: More cases in Europe
    Angeles Castel, Maria
    Perez-Villa, Felix
    Miro, Jose M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12) : 1418 - 1418
  • [4] [Anonymous], 2012, MEETING MATERIALS FO
  • [5] Fibrosing Cholestatic Hepatitis in HIV/HCV Co-Infected Transplant Patients-Usefulness of Early Markers After Liver Transplantation
    Antonini, T. M.
    Sebagh, M.
    Roque-Afonso, A. M.
    Teicher, E.
    Roche, B.
    Sobesky, R.
    Coilly, A.
    Vaghefi, P.
    Adam, R.
    Vittecoq, D.
    Castaing, D.
    Samuel, D.
    Duclos-Vallee, J. -C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) : 1686 - 1695
  • [6] Long-Term Outcomes of Orthotopic Liver Transplantation in Human Immunodeficiency Virus-Infected Patients and Comparison With Human Immunodeficiency Virus-Negative Cases
    Baccarani, U.
    Adani, G. L.
    Bragantini, F.
    Londero, A.
    Comuzzi, C.
    Rossetto, A.
    Lorenzin, D.
    Bresadola, V.
    Risaliti, A.
    Pea, F.
    Toniutto, P.
    Donini, A.
    De Anna, D.
    Bresadola, F.
    Tavio, M.
    Viale, P.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (04) : 1119 - 1122
  • [7] Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus
    Bani-Sadr, F
    Palmer, P
    Scieux, C
    Molina, JM
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1062 - 1064
  • [8] Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipients
    Barau, Caroline
    Blouin, P.
    Creput, Caroline
    Taburet, A. M.
    Durrbach, Antoine
    Furlan, Valerie
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 (04) : 423 - 425
  • [9] Bernard M. A., 2011, Morbidity and Mortality Weekly Report, V60, P297
  • [10] Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus
    Bhagat, Vishal
    Foont, Julie A.
    Schiff, Eugene R.
    Regev, Arie
    [J]. LIVER TRANSPLANTATION, 2008, 14 (01) : 92 - 95